The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of precision medicine in refractory malignancies: A meta-analysis of 13,203 patients in phase I clinical trials.
Maria Clemence Schwaederle
No Relationships to Disclose
Melissa M. Zhao
No Relationships to Disclose
J. Jack Lee
No Relationships to Disclose
Vladimir Lazar
No Relationships to Disclose
Brian Leyland-Jones
No Relationships to Disclose
Richard L. Schilsky
No Relationships to Disclose
John Mendelsohn
Leadership - Merrimack
Stock and Other Ownership Interests - Merrimack
Consulting or Advisory Role - MedImmune; ZIOPHARM Oncology
Patents, Royalties, Other Intellectual Property - ImClone Systems; Lilly
Razelle Kurzrock
Leadership - RScueRx Inc
Stock and Other Ownership Interests - Actuate Therapeutics; RScueRx
Honoraria - AACR; AACR; Actuate Therapeutics; Casdin Capital; Casdin Capital; Cedars-Sinai; Frankel Group; Global Biomarkers Consortium; Janssen; Jubilant Biosys; NCCN; NXT Health Strategies; Segal Cancer Center; Seminars in Oncology; Sequenom; Sequenom; Sequenom; Sequenom; Sequenom; Sequenom; The Dedham Group; UCSD Genomics Program Talk
Consulting or Advisory Role - AACR; CTRC-EAB San Antonio; Janssen; Jubilant Biosys; Merck; SAIC NCI CCCT IDSE; Sequenom
Speakers' Bureau - Guardant Health
Research Funding - Centocor Ortho Biotech; EMD Serono; EMD Serono; EMD Serono; Exelixis; Foundation Medicine; Genentech Mypath; GlaxoSmithKline; GlaxoSmithKline; Guardant Health; Merck; Merck; Novartis; Pfizer; Roche/Genentech; Sequenom; XBiotech
Patents, Royalties, Other Intellectual Property - Patent; Patent; Patent; Patent
Travel, Accommodations, Expenses - AACR; AACR; Association of American Cancer Institutes; Caris Centers of Excellence; Caris Centers of Excellence; EMD Serono; EMD Serono & Quintiles; Gateway Research Advisory Committee; Gateway Research Advisory Committee; Global Biomarkers Consortium; ICRP; WIN Pharma; WIN Pharma; WIN Pharma; WIN Pharma; WIN Pharma